Please try another search
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People’s Republic of China. The company’s products include Vastatin Calcium Tablets (Nile), Trimetazidine Hydrochloride capsules, Fanle type I and II tablets, Azathioprine tablets, Amiodarone Hydrochloride tablets, Hydroxyurea tablets, Colchicine tablets, etc. It also offers biological peptide products, food and beverages, cosmetics, and other products. The company was founded in 1980 and is based in Beijing, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Zheming Wei | 41 | 2016 | Chairman |
Wei Liu | 53 | 2016 | Co-Chairman & GM |
Hailin Yan | 46 | 2021 | Non-Independent Director |
Bin Wu | 63 | 2021 | Independent Director |
Weihong Sun | 60 | 2021 | Independent Director |
Sinian Chou | 41 | 2021 | Non-Independent Director |
Feng Han | 54 | 2022 | Director |
Ping Li | 49 | 2021 | Employee Supervisor |
Xin An Wang | 60 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review